Alnylam Pharmaceuticals Applauds Governor Deval Patrick’s Massachusetts’ Life Science Initiative Announced at Biotechnology Industry Organization (BIO) 2007

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, applauds Governor Deval Patrick’s announcement today at the BIO 2007 convention to make Massachusetts the global leader in life sciences, unveiling a comprehensive, collaborative Massachusetts Life Science Strategy. The plan includes a 10-year, $1 billion investment package that will both enhance the state’s already nationally recognized assets in the fields of medicine and science and bridge gaps in federal funding to ensure the state’s ability to support life science progress from the concept stage through the commercialization stage.
MORE ON THIS TOPIC